Scutellaria barbata D. Don inhibits migration and invasion of colorectal cancer cells via suppression of PI3K/AKT and TGF‑β/Smad signaling pathways

Jin,Yiyi; Chen,Wujin; Yang,Hong; Yan,Zhaokun; Lai,Zijun; Feng,Jianyu; Peng,Jun; Lin,Jiumao

doi:10.3892/etm.2017.5242

Scutellaria barbata D. Don inhibits migration and invasion of colorectal cancer cells via suppression of PI3K/AKT and TGF‑β/Smad signaling pathways

Authors:
- Yiyi Jin
- Wujin Chen
- Hong Yang
- Zhaokun Yan
- Zijun Lai
- Jianyu Feng
- Jun Peng
- Jiumao Lin
View Affiliations

Affiliations: Academy of Integrative Medicine, Biomedical Research Center, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian 350122, P.R. China, Oncology Department, The Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian 350004, P.R. China
Published online on: October 2, 2017 https://doi.org/10.3892/etm.2017.5242
Pages: 5527-5534

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Metastasis is one of the most aberrant behaviors of cancer cells. Patients with cancers, including colorectal cancer (CRC), have a higher risk of tumor recurrence and cancer‑related mortality once metastasis is diagnosed. Existing treatment strategies fail to cure cancer mostly due to the onset of metastasis. Therefore, metastasis remains a challenge in cancer treatment. Some complementary and alternative medical therapies using traditional Chinese medicine have been demonstrated to be clinically effective in cancer treatment. Scutellaria barbata D. Don (SB) is a promising medicinal herb. It was previously reported that the ethanol extract of SB (EESB) is able to promote apoptosis, and inhibit cell proliferation and angiogenesis in human colon cancer cells. However, the anticancer effect of SB and the underlying mechanism require further investigation, particularly its role against metastasis. To further elucidate the antimetastatic effect of SB, MTT and Transwell assays were used in the present study to evaluate the effect of EESB on the proliferation, migration and invasion of the CRC cell line HCT‑8. In addition, western blot analysis was performed to detect the expression of matrix metalloproteinases (MMPs), cadherins and other metastasis‑associated proteins. EESB significantly reduced HCT‑8 cell viability and attenuated the migration and invasion ability of HCT‑8 cells in a dose‑dependent manner. In addition, EESB decreased the expression of MMP‑1, MMP‑2, MMP‑3/10, MMP‑9 and MMP‑13, and proteins in the phosphoinositide 3‑kinase (PI3K)/AKT and transforming growth factor (TGF)‑β/Smad pathways, but not the epithelial‑mesenchymal transition (EMT)‑related factors E‑cadherin and N‑cadherin. In conclusion, the results suggested that SB inhibits CRC cell metastasis via the suppression of PI3K/AKT and TGF‑β/Smad signaling pathways, which may represent a mechanism by which SB exerts an anticancer effect.

View Figures

View References

1	Tenesa A and Dunlop MG: New insights into the aetiology of colorectal cancer from genome-wide association studies. Nat Rev Genet. 10:353–358. 2009. View Article : Google Scholar : PubMed/NCBI
2	Siegel R, Ma J, Zou Z and Jemal A: Cancer statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
3	Grávalos C, Cassinello J, Fernández-Rañada I and Holgado E: Role of tyrosine kinase inhibitors in the treatment of advanced colorectal cancer. Clin Colorectal Cancer. 6:691–699. 2007. View Article : Google Scholar : PubMed/NCBI
4	Brenner H, Kloor M and Pox CP: Colorectal cancer. Lancet. 383:1490–1502. 2014. View Article : Google Scholar : PubMed/NCBI
5	Van Cutsem E and Oliveira J: ESMO Guidelines Working Group: Advanced colorectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol. 20 Suppl 4:S61–S63. 2009. View Article : Google Scholar
6	Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J and Bouvier AM: Epidemiology and management of liver metastases from colorectal cancer. Ann Surg. 244:254–259. 2006. View Article : Google Scholar : PubMed/NCBI
7	Talmadge JE and Fidler IJ: AACR centennial series: The biology of cancer metastasis: Historical perspective. Cancer Res. 70:5649–5669. 2010. View Article : Google Scholar : PubMed/NCBI
8	Shen A, Lin W, Chen Y, Liu L, Chen H, Zhuang Q, Lin J, Sferra TJ and Peng J: Pien Tze Huang inhibits metastasis of human colorectal carcinoma cells via modulation of TGF-β1/ZEB/miR-200 signaling network. Int J Oncol. 46:685–690. 2015. View Article : Google Scholar : PubMed/NCBI
9	Kalluri R and Weinberg RA: The basics of epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428. 2009. View Article : Google Scholar : PubMed/NCBI
10	Xu T, Jing C, Shi Y, Miao R, Peng L, Kong S, Ma Y and Li L: microRNA-20a enhances the epithelial-to-mesenchymal transition of colorectal cancer cells by modulating matrix metalloproteinases. Exp Ther Med. 10:683–688. 2015. View Article : Google Scholar : PubMed/NCBI
11	Alam SK, Yadav VK, Bajaj S, Datta A, Dutta SK, Bhattacharyya M, Bhattacharya S, Debnath S, Roy S, Boardman LA, et al: DNA damage-induced ephrin-B2 reverse signaling promotes chemoresistance and drives EMT in colorectal carcinoma harboring mutant p53. Cell Death Differ. 23:707–722. 2016. View Article : Google Scholar : PubMed/NCBI
12	Guo S: Research progress in the mechanism of colorectal cancer metastasis. J Mudanjiang Med College. 29:65–67. 2008.
13	Juchniewicz A, Kowalczuk O, Milewski R, Laudański W, Dzięgielewski P, Kozłowski M and Nikliński J: MMP-10, MMP-7, TIMP-1 and TIMP-2 mRNA expression in esophageal cancer. Acta Biochim Pol. 64:295–299. 2017. View Article : Google Scholar : PubMed/NCBI
14	Yun EJ, Song KS, Shin S, Kim S, Heo JY, Kweon GR, Wu T, Park JI and Lim K: Docosahexaenoic acid suppresses breast cancer cell metastasis by targeting matrix-metalloproteinases. Oncotarget. 7:49961–49971. 2016. View Article : Google Scholar : PubMed/NCBI
15	Dou CY, Cao CJ, Wang Z, Zhang RH, Huang LL, Lian JY, Xie WL and Wang LT: EFEMP1 inhibits migration of hepatocellular carcinoma by regulating MMP2 and MMP9 via ERK1/2 activity. Oncol Rep. 35:3489–3495. 2016. View Article : Google Scholar : PubMed/NCBI
16	Fuksiewicz M, Kotowicz B, Rutkowski A and Kowalska M: The matrix metalloproteinase-7 and pro-enzyme of metalloproteinase-1 as a potential marker for patients with rectal cancer without distant metastasis. Tumour Biol. 36:3629–3635. 2015. View Article : Google Scholar : PubMed/NCBI
17	Zhang M, Zhuo N and Guo Z: Molecular mechanism of epithelial-mesenchymal transition and its role in tumor metastasis. Chin Med Herald. 11:163–165. 2014.
18	Wei F, Shen Q and Liu C: Phenethyl isothiocyanate inhibits PI3K/NF-kB to down-regulate MMP-9 expression in human colon cancer cells. Med Sci J Central South China. 42:351–354. 2014.
19	Liang S, Lv Y and Wang X: Study of the correlation and expression of focal adhesion kinase and matrix metalloproteinase-9 in colorectal carcinoma. J Colorectal Anal Surger. 14:157–160. 2008.
20	Gordaliza M: Natural products as leads to anticancer drugs. Clin Transl Oncol. 9:767–776. 2007. View Article : Google Scholar : PubMed/NCBI
21	Zhao J, Jiang P and Zhang W: Molecular networks for the study of TCM pharmacology. Brief Bioinform. 11:417–430. 2010. View Article : Google Scholar : PubMed/NCBI
22	Lin J, Chen Y, Wei L, Chen X, Xu W, Hong Z, Sferra TJ and Peng J: Hedyotis Diffusa Willd extract induces apoptosis via activation of the mitochondrion-dependent pathway in human colon carcinoma cells. Int J Oncol. 37:1331–1338. 2010.PubMed/NCBI
23	Demain AL and Zhang L: Natural Products and Drug Discovery. Can thousands of years of ancient medical knowledge lead us to new and powerful drug combinations in the fight against cancer and dementia? EMBO Rep. 10:194–200. 2009. View Article : Google Scholar : PubMed/NCBI
24	Shen AL, Hong F, Liu LY, Lin JM, Zhuang QC, Hong ZF and Peng J: Effects of Pien Tze Huang on angiogenesis in vivo and in vitro. Chin J Integr Med. 18:431–436. 2012. View Article : Google Scholar : PubMed/NCBI
25	Read BE: The Chinese Pharmacopoeia. Can Med Assoc J. 23:568–570. 1930.PubMed/NCBI
26	Cha YY, Lee EO, Lee HJ, Park YD, Ko SG, Kim DH, Kim HM, Kang IC and Kim SH: Methylene chloride fraction of Scutellaria barbata induces apoptosis in human U937 leukemia cells via the mitochondrial signaling pathway. Clin Chim Acta. 348:41–48. 2004. View Article : Google Scholar : PubMed/NCBI
27	Lin J, Chen Y, Cai Q, Wei L, Zhan Y, Shen A, Sferra TJ and Peng J: Scutellaria barbata D Don inhibits colorectal cancer growth via suppression of multiple signaling pathways. Integr Cancer Ther. 13:240–248. 2014. View Article : Google Scholar : PubMed/NCBI
28	Suh SJ, Yoon JW, Lee TK, Jin UH, Kim SL, Kim MS, Kwon DY, Lee YC and Kim CH: Chemoprevention of Scutellaria bardata on human cancer cells and tumorigenesis in skin cancer. Phytother Res. 21:135–141. 2007. View Article : Google Scholar : PubMed/NCBI
29	Yin X, Zhou J, Jie C, Xing D and Zhang Y: Anticancer activity and mechanism of Scutellaria barbata extract on human lung cancer cell line A549. Life Sci. 75:2233–2244. 2004. View Article : Google Scholar : PubMed/NCBI
30	Lee TK, Lee DK, Kim DI, Lee YC, Chang YC and Kim CH: Inhibitory effects of Scutellaria barbata D. Don on human uterine leiomyomal smooth muscle cell proliferation through cell cycle analysis. Int Immunopharmacol. 4:447–454. 2004. View Article : Google Scholar : PubMed/NCBI
31	Wei L, Chen Y, Lin J, Zhao J, Chen X, Xu W, Liu X, Sferra T and Peng J: Scutellaria barbata D. Don induces apoptosis of human colon carcinoma cell through activation of the mitochondrion-dependent pathway. J Med Plants Res. 5:1962–1970. 2011.
32	Wei L, Lin J, Wu G, Xu W, Li H, Hong Z and Peng J: Scutellaria barbata D. Don induces G1/S arrest via modulation of p53 and Akt pathways in human colon carcinoma cells. Oncol Rep. 29:1623–1628. 2013. View Article : Google Scholar : PubMed/NCBI
33	Georgescu MM: PTEN tumor suppressor network in PI3K-Akt pathway control. Genes Cancer. 1:1170–1177. 2010. View Article : Google Scholar : PubMed/NCBI
34	Rodel C, Hofheinz R and Liersch T: Rectal cancer: State of the art in 2012. Curr Opin Oncol. 24:441–447. 2012. View Article : Google Scholar : PubMed/NCBI
35	Cunningham D, Atkin W, Lenz HJ, Lynch HT, Minsky B, Nordlinger B and Starling N: Colorectal cancer. Lancet. 375:1030–1047. 2010. View Article : Google Scholar : PubMed/NCBI
36	Tan P, Lu B and Bao W: Analysis on the clinical application of Scutellaria barbata D. Don in the anti-cancer therapy. Jiangxi Tradit China Med. 37:57–58. 2006.
37	Dai ZJ, Liu XX, Tang W, Xue Q, Wang XJ, Ji ZZ, Kang HF and Diao Y: Antitumor and immune-modulating effects of Scutellaria barbata extract in mice bearing hepatocarcinoma H22 cells-derived tumor. Nan Fang Yi Ke Da Xue Xue Bao. 28:1835–1837. 2008.(In Chinese). PubMed/NCBI
38	Goh D, Lee YH and Ong ES: Inhibitory effects of a chemically standardized extract from Scutellaria barbata in human colon cancer cell lines, LoVo. J Agric Food Chem. 53:8197–8204. 2005. View Article : Google Scholar : PubMed/NCBI
39	Marconett CN, Morgenstern TJ, San Roman AK, Sundar SN, Singhal AK and Firestone GL: BZL101, a phytochemical extract from the Scutellaria barbata plant, disrupts proliferation of human breast and prostate cancer cells through distinct mechanisms dependent on the cancer cell phenotype. Cancer Biol Ther. 10:397–405. 2010. View Article : Google Scholar : PubMed/NCBI
40	Wong BY, Nguyen DL, Lin T, Wong HH, Cavalcante A, Greenberg NM, Hausted RP and Zheng J: Chinese medicinal herb Scutellaria barbata modulates apoptosis and cell survival in murine and human prostate cancer cells and tumor development in TRAMP mice. Eur J Cancer Prev. 18:331–341. 2009. View Article : Google Scholar : PubMed/NCBI
41	Zhao Z, Holle L, Song W, Wei Y, Wagner TE and Yu X: Antitumor and anti-angiogenic activities of Scutellaria barbata extracts in vitro are partially mediated by inhibition of Akt/protein kinase B. Mol Med Rep. 5:788–792. 2012.PubMed/NCBI
42	Zhang L, Cai Q, Lin J, Fang Y, Zhan Y, Shen A, Wei L, Wang L and Peng J: Chloroform fraction of Scutellaria barbata D. Don promotes apoptosis and suppresses proliferation in human colon cancer cells. Mol Med Rep. 9:701–706. 2014. View Article : Google Scholar : PubMed/NCBI
43	Herszényi L, Hritz I, Lakatos G, Varga MZ and Tulassay Z: The behavior of matrix metalloproteinases and their inhibitors in colorectal cancer. Int J Mol Sci. 13:13240–13263. 2012. View Article : Google Scholar : PubMed/NCBI
44	Littlepage LE, Sternlicht MD, Rougier N, Phillips J, Gallo E, Yu Y, Williams K, Brenot A, Gordon JI and Werb Z: Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression. Cancer Res. 70:2224–2234. 2010. View Article : Google Scholar : PubMed/NCBI
45	Laurie AS, Sandra JT and William GS: Matrix metalloproteinases: Changing roles in tumor progression and metastasis. Am J Pathol. 181:1895–1899. 2012. View Article : Google Scholar : PubMed/NCBI
46	Gao Y and Wang S: Relationship between matrix metalloproteinases and their inhibitors and their relationship with invasion and metastasis of malignant tumors. J New Med. 42:341–343. 2011.
47	Liu T, Ma Y and Zhang R: Advance research on relationship between matrix metalloproteinases and invasion and metastasis of malignant tumors. J Jilin Univ. 30:662–664. 2004.
48	Meng F, Liu X and Qi S: Correlation of matrix metalloproteinases-2 and-9 in ovarian cancer. Chin J Gerontology. 33:3505–3506. 2013.
49	Ming S, Sun T and Xiao W: Role of matrix metalloproteinases −2, −9 and its inhibitor 1 in the invasion and metastasis of lung cancer. Chin J Respirator Crit Care. 4:198–202. 2005.
50	Zheng H, Shen B, Nie Y and Du Y: The expression of MMP-9, MMP-13 and TIMP-3 in hepatocellular carcinoma. Guangdong Med J. 34:1995–1998. 2013.
51	Yan Z, Xu X and Yang G: Abnormal expression and clinical significance of matrix metalloprteinase 10 in esophagus carcinoma. Ningxia Med J. 27:14–15. 2005.
52	He J, Ding C, He G and Huang Q: Relationship between expression of ESM-1 and MMP-3 and invasion and metastasis of human hepatocellular carcinoma. Med Sci J Central South China. 40:368–372. 2012.
53	Yue X, Zhang Q, Xu A, Xing Y and Zhang F: Expression and clinical significance of MMP10 and CD105 in patients with non-small-cell lung carcinoma. Shandong Med J. 49:13–15. 2009.
54	Feng J, Gou W, Liu D and Li X: Expressions of matrix metalloproteinase-3 and matrix metalloproteinase-10 in endometrial carcinoma. J Xian Jiaotong Univ (Med Sci). 31:97–101. 2010.
55	Tian J, Xu M and Jing H: Matrix metalloproteinases 3 and its inhibitory factor 2 expression in lung squamous carcinoma. West China Med J. 28:369–372. 2013.
56	Ma R and Zhang C: Review of matrix metalloproteinases-13 and its relationship with invasion and metastasis of malignant tumor. J Community Med. 10:47–49. 2012.
57	Da C, Liu Y, Zhan Y, Liu K and Wang R: Nobiletin inhibits epithelial-mesenchymal transition of human non-small cell lung cancer cells by antagonizing the TGF-β1/Smad3 signaling pathway. Oncol Rep. 35:2767–2774. 2016. View Article : Google Scholar : PubMed/NCBI
58	Ji Q, Liu X, Han Z, Zhou L, Sui H, Yan L, Jiang H, Ren J, Cai J and Li Q: Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression. BMC Cancer. 15:972015. View Article : Google Scholar : PubMed/NCBI
59	Guo L and Wang Q: Correlation of PI3K/AKT/mTOR signal pathway to infiltration and metastasis of malignant tumor. Modern Oncol. 17:1585–1589. 2009.
60	Guo C, Ke W, Song K, Wang J, Zhou L and Li K: PI3K/AKT signalling pathway involves in the modulation of multidrug resistance and metastasis in breast cancer. Prog Mod Biomed. 12:4809–4812. 2012.
61	Jia BY and Wang YJ: Metastasis associated signaling pathway in colorectal cancer. Int J Dig Dis. 3:183–185. 2015.
62	Ding P, Song B and Zhu L: Effect of TGF-β/Smad 4 on the tumor metastasis of colorectal cancer cells. Chin J Cancer Prev Treat. 18:1518–1520. 2011.
63	Qi Y and Li H: Research of Qilian Fuzheng capsule's function on anti-lung cancer metastasis by regulating TGF-β pathway. Chin Archives Tradit Chin Med. 32:2567–2569. 2014.
64	Liotta LA: Tumor invasion and metastases-role of the extracellular matrix. Rhoads Memorial Award lecture. Cancer Res. 46:1–7. 1986.PubMed/NCBI
65	Stetler-Stevenson WG, Hewitt R and Corcoran M: Matrix metalloproteinases and tumor invasion: From correlation and causality to the clinic. Semin Cancer Biol. 7:147–154. 1996. View Article : Google Scholar : PubMed/NCBI
66	Chambers AF and Matrisian LM: Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst. 89:1260–1270. 1997. View Article : Google Scholar : PubMed/NCBI
67	Perera M, Tsang CS, Distel RJ, Lacy JN, Ohno-Machado L, Ricchiuti V, Samaranayake LP, Smejkal GB, Smith MG, Trachtenberg AJ and Kuo WP: TGF-beta1 interactome: Metastasis and beyond. Cancer Genomics Proteomics. 7:217–229. 2010.PubMed/NCBI
68	Roberts AB and Wakefield LM: The two faces of transforming growth factor beta in carcinogenesis. Proc Natl Acad Sci USA. 100:pp. 8621–8623. 2003, View Article : Google Scholar : PubMed/NCBI